Concepedia

Martin Svatoň

MS

13

Publications

334

Citations

11

H-Index

2012

Active since

Affiliations

Charles University(Current)

Masaryk University

Palacký University Olomouc

Genomac

University Hospital Brno

Martin Svatoň is an author at Charles University specializing in tumor microenvironment, tumor biology, and lung cancer.

ORCID

Top concepts

Publications per year

2012–2022

13

Publications

13

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer

Martin Svatoň, Milada Zemanová, Petra Zemanová et al. · Anticancer Research · 2020 · 82 citations · Full text

Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer

Martin Svatoň, Milada Zemanová, Jana Skřičková et al. · Anticancer Research · 2018 · 40 citations · Full text

The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy.

Martin Svatoň, Ondřej Fiala, Miloš Pešek et al. · PubMed · 2016 · 39 citations

Prognostic significance of TIMP-1 in non-small cell lung cancer

Martin Svatoň, Lukáš Řehoř, Vlastimil Kulda et al. · Lung Cancer · 2012 · 30 citations

, , +7

Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.

Ondřej Fiala, Miloš Pešek, Jindřich Fínek et al. · PubMed · 2016 · 24 citations

Rows per page

1–5 of 13